MedTrace Logo

Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients

NCT06763068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 575

Last updated 2025-01-08

No results posted yet for this study

Summary

The primary aim of this study was to quantify the diagnosis of pre-surgical skeletal muscle mass in elderly gastric cancer patients and to analyse its correlation with frailty. The second aim was to investigate whether skeletal muscle mass, or sarcopenia, is associated with mobility and nutritional status, and anxiety and depression. The main questions it aims to answer are whether skeletal muscle mass is significantly associated with frailty and whether it can be used as a brief screening tool for preoperative frailty.

Conditions

Interventions

OTHER

Skeletal muscle mass and frailty

Measurement correlation variable

Sponsors & Collaborators

  • Nanjing Medical University

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06763068 on ClinicalTrials.gov